Business Wire

NY-ALTER-DOMUS

23.1.2024 10:01:32 CET | Business Wire | Press release

Share
Alter Domus Solidifies Its Experience in Major Migrations With Creation of a Dedicated Key Client Partnerships Team as Private Markets Firms Reach Operational Tipping Point

Alter Domus, a leading provider of tech-enabled fund administration, private debt, and corporate services for the alternative investment industry, today unveiled the creation of its Key Client Partnerships (KCP) practice to help private markets firms scale their middle- and back-office infrastructure to meet increasing investor demands and mounting complexity. This creation comes as a natural consequence of the firm’s 20-year track record of building long-lasting relationships with major private markets firms.

As the pace of growth in the private markets continues to increase, so too has technology, regulatory and investor reporting requirements. In response, Alter Domus’ KCP practice aims to meet private markets firms’ need for dedicated support on defining and implementing new target operating models to support their future growth and scalability.

The Key Client Partnerships approach is centered on investing in long-term relationships with clients that covers everything from migrating products from one platform to another, to handling all outsourcing and technology interfacing, to managing all the governance and risk mitigation aspects of team and technology transitions.

Depending on their strategic priorities, joint operating models are built on one of three broad operational foundations:

  • Co-sourced: Alter Domus’ expert administration team continues to use a client’s technology, processes and data infrastructure. The benefits of this model include Alter Domus managing HR responsibilities for the client’s team, no disruptions from the client’s current model, and retention of any bespoke technology platform developments.
  • Managed service: An expert team actively manages a client’s technology and processes, while the client controls its data infrastructure. The advantages of this model include access to Alter Domus’ deep administration, technology and process expertise, its absorption of technology costs, and retention of bespoke data interfaces and developments on behalf of the client, as well as Alter Domus’ ongoing investments in technology platform upgrading and innovation.
  • Out-sourced: Alter Domus experts handle every aspect of a client’s administration needs, including technology and data infrastructure. Information is delivered through Alter Domus’ client portal, CorPro, or direct API connectivity. Alter Domus absorbs data and infrastructure costs and provides the client with full access to its industry-leading platforms, servicing and technology developments and innovation.

In addition, Alter Domus’ KCP team will support its clients in building the relevant financial model for the partnership, and lead the transition to the target operating model.

Alter Domus head of Key Client Partnerships Steve Krieger, said: “The focus of clients is investment management – raising money, deploying capital, managing risks – not fund servicing, accounting and compliance. Our new practice responds to private markets managers’ growing requirement for hands-on support on how to renew entire operating models that are no longer fit for purpose. Supported by our decades of administration expertise and industry-leading technology, fund managers can now partner with a dedicated team of Alter Domus experts to ‘co-create’ global operating models customized to their specific priorities.”

About Alter Domus
Alter Domus is a leading provider of tech-enabled fund administration, private debt, and corporate services for the alternative investment industry with more than 5,100 employees across 39 offices globally. Solely dedicated to alternatives, Alter Domus offers fund administration, corporate services, depositary services, capital administration, transfer pricing, domiciliation, management company services, loan administration, agency services, trade settlement and CLO manager services.

Find out more at www.alterDomus.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240123600245/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye